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Abstract
Background
Despite universal health care coverage, disparities in colorectal cancer (CRC) screening by
income in Switzerland have been reported. However, it is not known if these disparities
have changed over time. This study examines the association between socioeconomic
position and CRC screening in Switzerland between 2007 and 2012.
Methods
Data from the 2007 (n = 5,946) and 2012 (n = 7,224) population-based Swiss Health Inter-
view Survey data (SHIS) were used to evaluate the association betweenmonthly household
income, education, and employment with CRC screening, defined as endoscopy in the past
10 years or fecal occult blood test (FOBT) in the past 2 years. Multivariable Poisson regres-
sion was used to estimate prevalence ratios (PR) and 95% Confidence Intervals (CI) adjust-
ing for demographics, health status, and health utilization.
Results
CRC screening increased from 18.9% in 2007 to 22.2% in 2012 (padjusted: = 0.036). During
the corresponding time period, endoscopy increased (8.2% vs. 15.0%, padjusted:<0.001) and
FOBT decreased (13.0% vs. 9.8%, padjusted:0.002). CRC screening prevalence was greater
in the highest income (>$6,000) vs. lowest income ($2,000) group in 2007 (24.5% vs.
10.5%, PR:1.37, 95%CI: 0.96-1.96) and in 2012 (28.6% vs. 16.0%, PR:1.45, 95%CI: 1.09-
1.92); this disparity did not significantly change over time.
PLOS ONE | DOI:10.1371/journal.pone.0131205 July 6, 2015 1 / 14
OPEN ACCESS
Citation: Fedewa SA, Cullati S, Bouchardy C, Welle
I, Burton-Jeangros C, Manor O, et al. (2015)
Colorectal Cancer Screening in Switzerland: Cross-
Sectional Trends (2007-2012) in Socioeconomic
Disparities. PLoS ONE 10(7): e0131205. doi:10.1371/
journal.pone.0131205
Editor: Keping Xie, The University of Texas MD
Anderson Cancer Center, UNITED STATES
Received: March 22, 2015
Accepted: May 30, 2015
Published: July 6, 2015
Copyright: © 2015 Fedewa et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: This study used Swiss
Health Interview Survey (SHIS) data, which are
available for a fee (800 Swiss Francs for the 2007
and 2012 SHIS data), and users must request
permission to use the data from the Swiss Federal
Statistical Office (SFSO) by emailing the following
address: sgb12@bfs.admin.ch. Additionally, based
on SFSO guidelines, we are unable to release data
online.
Funding: This work was supported by the Swiss
Cancer League grant KLS-3144-02-2013.
Conclusions
While CRC screening prevalence in Switzerland increased from 2007 to 2012, CRC screen-
ing coverage remains low and disparities in CRC screening by income persisted over time.
These findings highlight the need for increased access to CRC screening as well as
enhanced awareness of the benefits of CRC screening in the Swiss population, particularly
among low-income residents.
Introduction
In 2012, 1,361,000 people were diagnosed with colorectal cancer (CRC) and 694,000 people
died from CRC worldwide. [1] The majority of CRCs are diagnosed in developed countries.
For example, world-age-standardized CRC incidence in New Zealand, Australia, Canada,
United States and Western Europe, including Switzerland, exceeds 25 cases per 100,000 people.
[1] In order to reduce CRC incidence and mortality, fecal occult blood testing (FOBT) annu-
ally, sigmoidoscopy every 5 years with hemoccult periodically or colonoscopy every 10 years
are recommended for average-risk adults between 50–75 years by European Panel [2] and the
US Preventive Services Task Force. [3] There is no national organized CRC screening program
in Switzerland and CRC screening among Swiss residents is low. According to the 2007 Swiss
Health Interview Survey (SHIS), only 13% of adults 50 years had a hemoccult test or endos-
copy in the past 5 years for screening reason. [4] In addition to suboptimal CRC screening utili-
zation in Switzerland, social inequalities have been noted where adults highest income bracket
were 70% more likely to receive a screening endoscopy.[4] However, temporal patterns of CRC
screening patterns by socioeconomic status have not been investigated, which is of interest
given a recent Swiss study reporting growing disparities in healthcare renunciation between
2007 and 2010 [5] and projected increases in CRC incidence.[6] The last population based
SHIS in 2012 provides an opportunity to examine temporal patterns of CRC screening by
socioeconomic status, measured by household income, education, and employment status.
This study examines the association between socioeconomic position and CRC screening prev-
alence as well as potential changes of social disparities between 2007 and 2012 in the SHIS.
Methods
Survey design
The SHIS is a cross-sectional survey repeated every 5 years since 1992 and conducted by the
Swiss Federal Statistical Office.[7] It is designed to be representative of all residents’ aged 15
years and older living in Switzerland, which are randomly selected following a two-stage strati-
fied sampling strategy. First, respondents were contacted by phone and interviewed using com-
puter–assisted telephone interview. Second, respondents received at home a self-administered
questionnaire (either paper or online). The response rate was 66.2% in 2007 and 53.1% in
2012.[8] Data are de-identified and according to Swiss law, de-identified routine health data do
not require approval by ethics committees.[9] The present study included the 2007 and 2012
waves because CRC screening questions were introduced only in 2007 and 2012 is the most
recent survey year available. We only examined respondents aged 50 to 75 years old
(N = 16,059), according to U.S and European CRC screening recommendations. [2, 3] We
excluded respondents with missing data on CRC screening use (N = 524), socio-economic or–
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demographic profile (N = 1,290), health status (N = 175), and health service use (N = 900). The
final study population included 13,170 individuals.
Dependent variables
Respondents were asked several CRC screening related questions as follows: 1) “Have you ever
had a hemoccult test?” 2) “Have you ever had a visual examination of the colon? (Endoscopy,
sigmoidoscopy, colonoscopy)?” If respondents answered yes to either question, the date and
the reason (diagnostic, screening or screening program) for the last test were ascertained.
Hemoccult tests included all FOBTs (guaiac, hemoccult) as well as fecal immunochemical test
(FIT). The analysis was restricted to screening related test. We considered only tests performed
within 2 years for the hemoccult and 10 years for endoscopy because sigmoidoscopy is rarely
performed (<4% of all CRC screenings) in Switzerland. [10] Three separate outcomes were
considered: hemoccult in the past 2 years, endoscopy in the past 10 years, and any CRC screen-
ing (hemoccult in the past 2 years or endoscopy in the past 10 years).
Independent variables
Three indicators of socioeconomic position were used: income ($2,000, $2,001–4000, $4,001-
$6,000,>$6,000), education (compulsory, secondary, and tertiary), and employment
(employed vs. out of the labor force). Among employed respondents, occupational class (lib-
eral, intermediate, non-manual professions, independent/artisans, overseer/qualified worker,
skilled worker) were also considered. Household income was weighted by the number of per-
sons living in the household. In October 2014, 1 US dollar (USD) corresponded to 1 Swiss
Franc (CHF). Educational levels generally corresponded to the International Standard Classifi-
cation of Education 1997[11]: compulsory education corresponded to primary and lower sec-
ondary education (approximately 9 years of education starting at age 4 or 5), secondary
education includes additional specialized training including vocational training (approximately
1–3 years of additional education), and tertiary included more theory-based and specialized
degrees which correspond to bachelors, masters and doctoral degrees (approximately an extra
1–8 years of education). Occupational class was based on the Erikson, Goldthorpe and Porto-
carero social class scheme [12] which classified occupation based on job duties, setting/envi-
ronment and management responsibilities.
Other sociodemographic characteristics included sex, age (50–64, 65–75), marital status
(single, married/registered partnership, widow, divorced/separated/registered partnership dis-
solved), and citizenship (Swiss versus not Swiss). Geographic residence was grouped as: metro-
politan areas, medium size urban areas, small size urban areas, and rural areas.
Health status covariates included self-rated health (SRH), physical symptoms, psychological
distress, health service use, smoking (current versus former/never smoker) and body mass
index (BMI). The SRH questions varied between the two surveys. In 2007, respondents were
asked “How is your health in general?” and response categories included very good, good, good
enough, bad, and very bad. In 2012, respondents were asked “How is your health condition in
general?” and response categories included very good, good, average, bad and very bad. SRH
was categorized as very good, good, average/good enough, bad and very bad to capture the dif-
ferent response categories over the two surveys. Respondents were asked about the presence
and frequency of the following eight physical symptoms in the past four weeks: backache, gen-
eral weakness, stomach ache/bloating, diarrhea/constipation, insomnia, headache, cardiac
arrhythmia, chest pain. The total number of physical symptoms in the past four weeks was
classified as: no or a few (<10), some (10 to<12) and many (12). Psychological distress was
ascertained from the five item Mental Health Index, a subscale of the SF-36[13] where
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respondents were asked how often (all, most, good bit, some, little, or none) they experienced
five mental states in the last four weeks (have you been a very nervous person? Have you felt so
down in the dumps that nothing could cheer you up? Have you felt calm and peaceful? Have
you felt downhearted and blue? Have you been a happy person?). Psychological distress was
classified intro three levels of distress: high (52), moderate (53 to 72) and low (73). BMI
was grouped into four groups: underweight (<18.5), normal weight (18.5 to<25), overweight
(25 to<30) and obesity (30).
Health services covariates included having visited a general practitioner or family doctor
visit (yes/no), specialist visit (yes/no) and hospitalization (yes/no) in the last 12 months.
Statistical analysis
Descriptive statistics of respondents' characteristics were reported using weighted proportions.
These weights were used to account for complex survey design and non-participating bias. Dif-
ferences between 2007 and 2012 were tested using unweighted chi-square test. Poisson regres-
sion models with robust variance estimators were used to estimate adjusted prevalence ratios
(PR) and 95% confidence intervals (95%CI). Variance inflation factors were used to assess
potential collinearity among socioeconomic variables and collinearity was not detected. For the
main analyses, models were stratified by year and were adjusted for education, household
income, employment status, demographic factors, health status, and health services use as
described above. These variables were a priori considered given their potential associations
with screening. [14] For socioeconomic indicators, different coding schemes were examined
(education using three to five levels, income as a continuous versus nominal variable, employ-
ment in three versus two levels, occupational class in four versus six levels) to check robustness
of results and results were similar (data not shown). Trends between 2007 and 2012 were tested
by adding a wave (2012 vs. 2007) and predictor product term models. Trends were examined
for the three CRC screening definitions described above. A model restricted to employed adults
was conducted to examine the association between occupational class and CRC screening. All
analyses were conducted with SPSS 22 and STATA 11.
Sensitivity analyses
Since individuals aged 50–59 years did not have a full 10 years in which they could have
received endoscopy, we conducted sensitivity analyses restricted to respondents’ aged 60–75
years. The same analyses were conducted with respondents’ aged 52–75 for hemoccult utiliza-
tion. We also conducted additional analyses accounting for supplemental insurance (no, half-
private or private) to see if the relationship between household income and CRC screening was
altered.
Results
5,946 and 7,224 respondents from the 2007 and 2012 SHIS were analyzed, respectively.
Respondent socioeconomic characteristics varied between the two surveys. (Table 1) The
median household income increased from $4,000 in 2007 to $4,130 in 2012. During the study
period, there was a 5.2% decrease in respondents with secondary education and 7.2% increase
in respondents reporting part or full-time employment. The proportion of divorced or sepa-
rated respondents increased between 2007 and 2012. In terms of health indicators, obesity and
psychological distress prevalence increased slightly between 2007 and 2012, while physical
symptoms decreased during the period. Health services use also varied with time. The propor-
tion of respondents reporting visiting a general practitioner within the past year declined from
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Table 1. Respondent Characteristics by Survey Year Among Adults 50–75 years of age from Swiss Health Interview Survey 2007 and 2012
(n = 13,170).
2007N = 5946 2012N = 7224
Socioeconomic characteristics N (%)1 N (%)1 p-value2
Household Income (USD)3 <0.001
2000 555(8.2) 514(7.2)
2001–4000 2692(45.8) 3087(42.7)
4001–6000 1708(28.9) 2264(31.7)
>6000 991(17.2) 1359(18.5)
Education <0.001
Compulsory 801(11.4) 1029(14.0)
Secondary 3631(60.9) 4129(55.7)
Tertiary 1514(27.7) 2066(30.3)
Employment status <0.001
Out of the labour force 3077(46.1) 2964(38.9)
Employed Full or Part-Time 2869(53.9) 4260(61.1)
Occupational Class Among Employed (n = 7,129) 0.002
Liberal/Intermediate professions 1198(42.4) 1760(42.0)
Non-manual professions 528(17.2) 676(15.2)
Independent, artisan 516(17.3) 896(20.3)
Overseer, qualiﬁed worker and skilled worker 627(23.1) 928(22.5)
Sociodemographic characteristics
Age (years) 0.002
50–64 3727(68.0) 4717(66.6)
65–75 2219(32.0) 2507(33.4)
Sex <0.001
Male 2694(50.8) 3528(50.5)
Female 3252(49.2) 3696(49.5)
Marital status <0.001
Single 571(6.7) 666(8.8)
Married and Registered partnership 3552(72.0) 4960(67.7)
Widow 806(8.2) 484(6.5)
Divorced/Separated 1017(13.2) 1114(17.0)
Citzenship <0.001
Swiss 5532(88.9) 6434(86.4)
Not Swiss 414(11.1) 790(13.6)
Urban areas <0.001
Metropolitan areas 2480(52.8) 3434(51.9)
Medium size urban areas 1601(23.3) 1709(24.1)
Small size urban areas 951(11.7) 1161(11.8)
Rural areas 914(12.4) 920(12.2)
Health status
Self-rated health <0.001
Very bad or bad 252(3.9) 360(4.6)
So-so 819(12.6) 1265(17.3)
Good 3861(66.3) 3370(47.3)
Very good 1014(17.2) 2229(30.8)
Body mass index <0.001
Underweight 134(1.9) 163(2.0)
Normal weight 2930(48.5) 3315(45.3)
(Continued)
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81.5% in 2007 to 72.4% in 2012 whereas specialist visits increased slightly from 39.8% in 2007
to 43.0% in 2012 (Table 1).
Prevalence and trends of CRC screening reasons
Overall, CRC screening from either modality increased from 18.9% in 2007 to 22.2% in 2012
(adjusted p-value = 0.036). (Fig 1) This increase was due to growing endoscopy utilization,
which rose from 8.2% in 2007 to 15.0% in 2012 (adjusted p-value<0.001). During the same
period, hemoccult utilization decreased from 13.0% to 9.8% (adjusted p-value = 0.002). (Fig 1)
The prevalence of CRC screening from either modality was 10% higher in 2012 compared to
2007 (PR = 1.10, 95%CI: 1.01–1.21) after adjusting for socioeconomic as well as demographic,
health status and health utilization factors. The adjusted for prevalence of endoscopy was 44%
higher in 2012 compared to 2007 (PR = 1.44, 95%CI: 1.26–1.65) whereas the adjusted preva-
lence of hemoccult use was 18% lower (PR = 0.82, 95%CI: 0.73–0.93).
Table 1. (Continued)
2007N = 5946 2012N = 7224
Socioeconomic characteristics N (%)1 N (%)1 p-value2
Overweight 2180(38.2) 2724(38.4)
Obesity 702(11.3) 1022(14.2)
Physical symptoms4 <0.001
No, a few 2255(41.4) 3363(49.1)
Some 1990(35.3) 2172(30.9)
Important 1427(23.3) 1429(20.0)
Psychological distress5 0.010
High 240(3.5) 347(4.5)
Moderate 675(10.8) 909(12.8)
Low 4935(85.8) 5892(82.7)
Currently smoking 0.523
Yes 1394(23.3) 1728(23.6)
No 4552(76.7) 5496(76.4)
Hospitalization last 12 months 0.577
No 5156(87.2) 6288(87.7)
yes 790(12.8) 936(12.3)
Health service use
General practitioner visit(s) past 12 months <0.001
No 1060(18.5) 1951(27.6)
Yes 4886(81.5) 5273(72.4)
Specialist visit(s) past 12 months <0.001
No 3571(60.2) 4064(57.0)
Yes 2375(39.8) 3160(43.0)
1 Proportions are weighted.
2 Unweighted Pearson Chi-square test.
3 In October 2014, $1US Dollar = 1 CHF = 0.8 EUR.
4.Missing on 570 respondents
5 Missing on 208 respondents.
doi:10.1371/journal.pone.0131205.t001
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Socioeconomic determinants of CRC screening and temporal trends
Income. In 2007, the prevalence of CRC screening was 24.5% among respondents with
higher income (>$6,000) and 10.5% among respondents with low income (<$2,000). In 2012,
the corresponding percentages were 28.6% and 16.0%. (S1 Table). Household income
remained positively associated with any CRC screening after adjusting for education, employ-
ment status, demographics, health status, and health service use. In adjusted analyses, CRC
screening prevalence was 37% higher (not significantly) in high income respondents (>$6,000)
compared to low income respondents ($2,000) in 2007 (PR = 1.37, 95%CI:0.96–1.96). In
2012, CRC screening was 45% higher in high vs. low income respondents (PR = 1.45, 95%
CI:1.09–1.92) (Table 2). However, the test for temporal trend in CRC screening by household
income was not significant (p-value for trend = 0.397). When endoscopy and hemoccult were
examined separately, high income was associated with endoscopy use in 2007 and 2012 (2007
PR = 1.78, 95%CI: 1.01–3.12 and 2012 PR = 1.75, 95%CI: 1.21–2.54), but there was no associa-
tion between income and hemoccult use in either year after adjusting for covariates.
Education, employment status and occupational class. Education and employment were
not independently associated with CRC screening in adjusted analyses (Table 2). However, in
2007, hemoccult was lower among employed compared unemployed respondents, but no asso-
ciation was observed in 2012 (Table 2). In analyses restricted to respondents in the labor force
(N = 7,129, 54.1% of the sample), independent (PR = 1.53, 95%CI: 1.09–2.16), non-manual
employee (PR = 1.49, 95%CI:1.00–2.22), and superior professions (PR = 1.49, 95%CI:1.07–
2.06) had significantly higher endoscopy utilization in 2012 compared to respondents with
manual professions (S2 Table). This association was not apparent in 2007, however a temporal
trend was not significant (p-value for trend = 0.104) (S2 Table).
Fig 1. Colorectal Cancer ScreeningWeighted Prevalence among Respondents Aged 50–75 years of
age from Swiss Health Interview Survey 2007–2012.Hemoccult in past 2 years 2007 vs 2012 (p-
value = 0.002). Endoscopy in past 10 years 2007 vs 2012 (p-value<0.001). Any CRC screening (Hemoccult
in past 2 years or endoscopy in past 10 years or both) 2007 vs 2012 (p-value = 0.036). P-values are adjusted
for education, household income, employment, age, sex, marital status, citizenship, urban/rural status, health
status and health care use.
doi:10.1371/journal.pone.0131205.g001
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Other sociodemographic factors
Rural residence was associated with increased CRC screening (hemoccult or colonoscopy)
compared to urban residence in 2007 (PR = 1.24, 95%CI 1.00–1.52), but not in 2012 (p-value
for trend = 0.007) (Table 2). A similar pattern was observed when endoscopy and hemoccult
were considered separately, however, the test for trend was only significant for endoscopy. Age
and marital status were generally not associated with CRC screening, though married respon-
dents had higher hemoccult prevalence in 2012 compared to 2007compared to their single/
divorced/widowed counterparts (p-value for trend = 0.006)–a trend confirmed in analyses
restricted to respondents in the labor force (S2 Table). Women were less likely to receive CRC
screening compared to men and their use of hemoccult declined significantly over time (p-
value for trend = 0.014).
Health service use
Health services use, as measured by visiting a general practitioner in the past 12 months, was
associated with higher prevalence of CRC screening overall in 2007 and 2012(Table 2). Visiting
a general practitioner was also positively associated when hemoccult and endoscopy were ana-
lyzed separately. Visiting a specialist, including a gastroenterologist, was significantly related to
endoscopy use in both 2007 and 2012.
Sensitivity analyses
In sensitivity analyses restricted to adults aged 52–75 or 60–75, results were generally similar to
those presented in our primary results among those aged 50–75, though among older (60–76)
respondents, GP visits were not associated with endoscopy use (data not shown). However,
adjustment for supplemental insurance (no, half-private or private) attenuated to the associa-
tion between income and CRC screening (data not shown).
Discussion
This study is the first to examine nationwide CRC screening trends in Switzerland. While CRC
screening prevalence increased between 2007 and 2012, CRC screening utilization remains
low, especially among adults with low income. The growth in CRC screening prevalence was
due to greater use of endoscopy, which is in line with screening patterns in the United States.
[15, 16] Yet, CRC screening prevalence in Switzerland (22%) is lower than the US where 58%
of eligible adults are up to date with CRC screening. [17] Additionally, CRC screening preva-
lence in Switzerland, which does not have an organized CRC screening program, is consider-
ably lower than in other European countries with organized screening programs [18–20] but
similar to European countries (e.g: Belgium, Netherlands and Denmark) without organized
screening programs. [20] Our CRC screening prevalence estimates were similar to other previ-
ous population-based estimates, but lower than surveys among hospital series, which is likely
due to differences in study populations and we excluded diagnostic hemoccult and endosco-
pies. [10, 21]
Disparities in CRC screening by income persisted between 2007 and 2012 where adults with
higher incomes had greater CRC screening utilization. These findings are consistent with other
reports in Europe [18, 22], including a previous Swiss study.[4] The association between
income and CRC screening in our study is likely due to a number of factors, including more
financial barriers. Despite universal health care in Switzerland where healthcare costs, medical
coverage and life expectancy are among the highest in the world, out of pocket expenses and
health insurance premiums, which increased by 18% between 2007 and 2012, are substantial.
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[23] For example, during our study period, individuals were responsible for a 10% co-payment
(up to annual limit of 700 CHF) for screening-related CRC tests after their annual deductible
(which ranges from 300–2,500 CHF) was met, though patients/physicians may have been moti-
vated to misrepresent symptoms in order to have their tests deemed diagnostic, and thus cov-
ered by insurance during this time. [4] A recent study reports that approximately 13% of Swiss
forgo healthcare for economic reasons and this proportion is much higher among those in the
lowest income (30%) compared to highest income bracket (4%).[5] Beginning July 2013, rou-
tine CRC screening (FOBT every 2 years and colonoscopy every 10 years) was fully in Switzer-
land covered under basic compulsory healthcare coverage, however, it is not known how these
changes have affected CRC screening utilization.
Though cost is likely a barrier to CRC screening among low-income respondents, there are
several other ways in which income may influence CRC screening. A favorable attitude toward
screening is an important predictor of cancer screening, which is not only lower among lower-
income individuals, but has been shown to mediate the association between income and cancer
screening. [24] Furthermore, lower income is associated with lower adherence to free and orga-
nized CRC screening programs in other European counties where individuals were mailed an
at-home FOBT kit. [18, 22] Such national programs would in theory, minimize such barriers
as time off work and transportation issues. [18, 22]
Income disparities in CRC screening utilization persisted over our 5-year study period. A
previous Swiss study reported a growing, but not statistically significant, proportion of health-
care renunciation for financial reasons between 2007 and 2010 among low-income residents.
[5] Despite the global financial crisis in 2008, the overall economic impact on Switzerland has
been minimal as unemployment, average number of hours worked per week, and income
remained stable between 2007 and 2012.[25] Though the overall economic condition in Swit-
zerland is positive, there may be subgroups of the population that may equally experience the
positive economic condition which is reflected in the continued CRC screening disparity by
income.
In terms of other socioeconomic measures, we did not observe an independent association
between education and CRC screening use. In contrast, North American studies report positive
associations between CRC and education independent of income.[14, 26] Previous studies in
Switzerland have not observed an association with education, CRC mortality[27] and frailty
[28], which could be due to narrower ranges of education attainment in Switzerland. Addition-
ally, employment status (unemployed versus employed) was not associated with CRC screen-
ing, which is consistent with other findings. [29, 30] Among employed respondents, CRC
screening prevalence was higher among professionals relative to manual laborers. The differ-
ence was mostly based on the 2012 survey and was largely unexplained, though it may be due
to residual confounding by income level. Additional research on whether these differences will
increase in the future, or if it’s due to random fluctuation is warranted.
We observed notable temporal changes by geographic residence. In 2007, rural respondents
had higher CRC screening prevalence compared to urban respondents, while the opposite was
observed in 2012. Changes in physician density may explain temporal patterns. Though medi-
cal density has increased markedly since the 1950’s, [31] in 2002, the Swiss government froze
new accreditations for private practice physicians for a period of three years in order to reduce
healthcare expenditures [32], renewed this decision for a supplementary period of three years
(until 2008)[31] but only for specialists, until 2011. Initial reports noted a decline in general
practitioners,[33] with an increase after the "freezing" period (2009–2011)[34] however, the
continuation of these effects during the time of our study and the potential differential impact
on rural versus urban regions is unknown. Studies examining regional variations in medical
demography [35–37] are based on the Swiss cantons, not on the urban/rural variable, limiting
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the possibility of comparison with the existing literature. Additionally, we did not observe an
association between health status and CRC screening.
Limitations and Strengths
There are several limitations of our study worth noting. We did not have information on family
history of CRC which strongly influences CRC screening adherence.[14] Though the preva-
lence of CRC family history in Switzerland has not been reported, prevalence of CRC family
history in the US (which has similarly high incidence rates as Switzerland[38]) is low (<10%).
[39, 40] Therefore, the degree to which family history of CRC confounds our results is likely to
be minor. Selection bias may also be an issue in our study as SHIS response rates ranged from
53–66%. Non-responders have lower socioeconomic status [8] and may also have lower CRC
screening utilization, leading to underestimation of CRC screening disparities by income.
However, our use of weighted prevalence ratios mitigates the magnitude of this bias. Despite
efforts to ask respondents in lay language about CRC test, there may have been misclassifica-
tion of receipt of colonoscopy or hemoccult due to respondents not understanding the question
or having inaccurate recall. Validation studies of self-reported cancer screening indicate that
respondents may overestimate screening, though the degree of CRC screening misclassification
is moderate. [41] Additionally, we were unable to differentiate between sigmoidoscopy and
colonoscopy, which have different recommended scheduling (5 versus 10 years). However, it is
reasonable to assume that the majority of endoscopies performed were colonoscopies as a pre-
vious Swiss study reported very low utilization of sigmoidoscopy.[10] Income data from the
SHIS has not been validated and respondents may have overestimated their income. Further-
more, we excluded 1,697 (10.9%) respondents due to missing information on screening, socio-
demographic, health status, and health service use, which may introduce selection bias though
the proportion of respondents excluded due to missing information (10.9%) is small, limiting
the magnitude of bias.
Despite these limitations our study has several strengths including our ability to differentiate
between screening and diagnostic procedure and to assess various dimensions of socioeco-
nomic position in a large population-based sample. Additionally, all analyses were weighted
and corrected for sampling strategy which minimizes the risk of non-answer bias by sociode-
mographic factors and health status. This increases our confidence for population-based esti-
mates of CRC screening in Switzerland. Additionally, we were able to adjust for many known
risk factors for CRC cancer including smoking and obesity.
Conclusion
This study is the first to examine nationwide changes CRC screening in Switzerland. While
CRC screening prevalence in Switzerland increased from 2007 to 2012, CRC screening utiliza-
tion remains insufficient. Additionally, low income Swiss residents had particularly inadequate
CRC screening prevalence and this disparity persisted over time. These findings highlight the
need for tailored interventions to increase the access to CRC screening, as well as increasing
awareness of the benefits of CRC screening in the Swiss population, particularly among low-
income residents. Additionally, the impact of adding CRC screening as a covered benefit to the
basic Swiss health insurance plans in 2013 needs to be determined.
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